HolderBook

Ikarian Capital, LLC

Reported holdings as of Q2 2026, from 27 quarterly filings.

CIK
1778253
Reported value
$928.2M
Positions
137
Top 10 weight
47.1%
Filed
2026-08-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
ABIVAX SA OPTABVX$122.1M328,63513.16%+10.00pp4q+470.2%+$100.7M
IONIS PHARMACEUTICALS INC OPTIONS$55.5Moptions only5.98%+4.52pp4qOPTIONS
KODIAK SCIENCES INC OPTKOD$49.8M1,059,7305.36%+1.13pp14q-16.3%-$9.7M
SPDR SERIES TRUST OPTXBI$47.5Moptions only5.11%-3.18pp4qOPTIONS
ALUMIS INC OPTALMS$34.5M870,5483.72%+1.08pp3q-28.3%-$13.6M
PRAXIS PRECISION MEDICINES I OPTPRAX$31.4M72,8423.38%+1.51pp6q+1.8%+$543.3K
MODERNA INC OPTMRNA$28.0Moptions only3.02%-newOPTIONS
CAPRICOR THERAPEUTICS INC OPTCAPR$23.0M604,2152.48%+0.31pp8q+14.4%+$2.9M
VAXCYTE INCPCVX$22.6M388,6822.43%+0.41pp6q-9.3%-$2.3M
ANI PHARMACEUTICALS INCANIP$22.5M272,0852.43%+0.57pp3q+85.0%+$10.3M
CELLDEX THERAPEUTICS INC NEW OPTCLDX$22.0M478,5002.38%+0.89pp2q+3.7%+$794.9K
TENAX THERAPEUTICS INC OPTTENX$17.1M787,6001.85%+0.38pp4q-22.6%-$5.0M
VERA THERAPEUTICS INC OPTVERA$16.4M310,0001.76%+0.88pp2q+55.0%+$5.8M
ARCUS BIOSCIENCES INCRCUS$15.6M504,5591.68%-newNEW
RELMADA THERAPEUTICS INCRLMD$14.9M2,148,3591.60%+0.08pp22q-20.1%-$3.7M
COGENT BIOSCIENCES INCCOGT$14.3M370,0841.54%-newNEW
NEWAMSTERDAM PHARMA COMPANY OPTNAMS$13.6Moptions only1.46%-newOPTIONS
CONTINEUM THERAPEUTICS INCCTNM$13.2M807,8741.43%+0.57pp3qHELD
C4 THERAPEUTICS INCCCCC$11.4M2,433,0001.22%-newNEW
MAZE THERAPEUTICS INCMAZE$11.3M378,9991.22%+0.27pp6qHELD
ARROWHEAD PHARMACEUTICALS IN OPTARWR$11.3M38,2781.21%+0.92pp2qHELD
BIOHAVEN LTDBHVN$11.1M748,1811.20%+0.92pp3q+81.4%+$5.0M
CONNECT BIOPHARMA HLDGS LTDCNTB$10.8M4,538,5341.16%+0.07pp3q-15.8%-$2.0M
ALTO NEUROSCIENCE INCANRO$10.7M407,3381.16%+0.22pp8q-20.9%-$2.8M
PHARVARIS N VPHVS$10.7M308,8561.15%+0.03pp4q-36.6%-$6.2M
EYEPOINT INC OPTEYPT$10.6Moptions only1.14%+0.37pp2qOPTIONS
JADE BIOSCIENCES INCJBIO$9.5M427,3491.02%+0.44pp3q-16.6%-$1.9M
DAMORA THERAPEUTICS INCDMRA$8.7M335,7100.94%+0.23pp3qHELD
Q32 BIO INC OPTQTTB$8.0M430,0000.86%-newNEW
VIRIDIAN THERAPEUTICS INCVRDN$7.8M425,0000.84%-newNEW
OLEMA PHARMACEUTICALS INC OPTOLMA$7.3M383,2810.79%-0.60pp3q-35.9%-$4.1M
PELTHOS THERAPEUTICS INCPTHS$7.3M256,5980.78%+0.34pp4qHELD
ZURA BIO LTDZURA$7.2M1,218,4920.77%+0.20pp4q+2.1%+$147.5K
TECTONIC THERAPEUTIC INCTECX$7.1M205,8370.76%+0.37pp2q+30.7%+$1.7M
SPRUCE BIOSCIENCES INCSPRB$6.6M121,3560.71%+0.06pp4qHELD
HIMS & HERS HEALTH INCHIMS$6.5M188,3810.70%-newNEW
ENLIVEN THERAPEUTICS INCELVN$6.4M126,5410.69%+0.43pp2qHELD
PROQR THRAPEUTICS N VPRQR$6.4M3,425,9300.69%+0.49pp5q+129.6%+$3.6M
BRIGHT MINDS BIOSCIENCES INCDRUG$6.2M88,9510.67%-0.31pp7q-46.6%-$5.5M
OVID THERAPEUTICS INCOVID$6.1M2,269,7040.66%+0.14pp4q-21.6%-$1.7M
OCUGEN INCOCGN$6.1M3,962,9720.65%+0.07pp2qHELD
ALPHA COGNITION INCACOG$6.0M836,2590.65%+0.18pp7q-20.8%-$1.6M
KYMERA THERAPEUTICS INC OPTKYMR$5.8Moptions only0.62%+0.28pp2qOPTIONS
HARROW INCHROW$5.8M135,7750.62%-0.93pp4q-75.0%-$17.3M
KAZIA THERAPEUTICS LTDKZIA$5.6M396,2010.60%-newNEW
ULTRAGENYX PHARMACEUTICAL INRARE$5.5M165,6170.60%-0.23pp8q-65.7%-$10.6M
EUPRAXIA PHARMACEUTICALS INCEPRX$5.4M809,7410.58%-0.14pp3q-33.3%-$2.7M
SELLAS LIFE SCIENCES GROUP I OPTSLS$5.2Moptions only0.56%-newOPTIONS
BIOAGE LABS INCBIOA$4.9M200,0000.53%-newNEW
REZOLUTE INCRZLT$4.9M935,0120.52%+0.52pp3q+5574.0%+$4.8M
SIONNA THERAPEUTICS INC OPTSION$4.7Moptions only0.51%-newOPTIONS
MONOPAR THERAPEUTICS INCMNPR$4.4M47,8610.48%-newNEW
BRIDGEBIO PHARMA INCBBIO$4.3M57,4170.46%-0.86pp2q-64.1%-$7.6M
INVENTIVA SAIVA$4.2M1,129,1010.45%-0.19pp3q-21.0%-$1.1M
ABSCI CORPORATIONABSI$4.1M353,7720.44%-newNEW
ALECTOR INCALEC$4.0M1,982,6060.43%+0.07pp7q-4.8%-$201.0K
CLIMB BIO INCCLYM$3.9M300,0000.42%-newNEW
FULCRUM THERAPEUTICS INCFULC$3.8M1,049,1610.41%-0.24pp8qHELD
CARDIOL THERAPEUTICS INCCRDL$3.5M3,325,0000.38%+0.08pp2q+22.0%+$636.0K
CUE BIOPHARMA INCCUE$3.3M104,3640.35%-newNEW
CUMBERLAND PHARMACEUTICALS ICPIX$3.3M503,1530.35%+0.21pp6q-9.0%-$324.0K
REIN THERAPEUTICS INCRNTX$3.1M2,950,0000.33%-newNEW
ARVINAS INCARVN$3.0M358,2570.32%+0.01pp6qHELD
ACUMEN PHARMACEUTICALS INCABOS$2.8M1,053,7970.30%+0.10pp16qHELD
PROMIS NEUROSCIENCES INCPMN$2.7M205,0000.29%+0.23pp2q+272.7%+$2.0M
ANNEXON INCANNX$2.5M430,2440.26%flat3q-25.9%-$856.5K
BRISTOL-MYERS SQUIBB CO OPTBMY$2.4Moptions only0.26%-2.20pp2qOPTIONS
LEXEO THERAPEUTICS INCLXEO$2.4M513,0110.26%+0.02pp8qHELD
DELCATH SYS INCDCTH$2.3M185,6670.25%-0.07pp9q-56.9%-$3.1M
INVIVYD INCIVVD$2.3M2,656,5700.25%-0.03pp4qHELD
UNIQURE NV OPTQURE$2.3Moptions only0.25%-0.22pp5qOPTIONS
CABALETTA BIO INCCABA$2.2M700,0000.23%+0.04pp3q-22.2%-$622.0K
NEUMORA THERAPEUTICS INC.NMRA$2.2M1,278,4080.23%+0.03pp8qHELD
AMYLYX PHARMACEUTICALS INCAMLX$2.1M117,5000.23%-newNEW
TARSUS PHARMACEUTICALS INCTARS$2.0M31,1660.21%+0.03pp12qHELD
DISC MEDICINE INC OPTIRON$1.9Moptions only0.21%-newOPTIONS
SILENCE THERAPEUTICS PLCSLN$1.8M830,7840.20%+0.06pp5q-4.0%-$77.0K
JOURNEY MED CORPDERM$1.8M251,4360.19%+0.10pp3qHELD
DBV TECHNOLOGIES S ADBVT$1.7M525,0000.18%flat3qHELD
IBIO INCIBIO$1.7M957,0620.18%+0.03pp10qHELD
AVALO THERAPEUTICS INCAVTX$1.7M90,1830.18%-0.50pp10qHELD
ANTERIS TECHNOLOGIES GLOBALAVR$1.6M166,5710.18%+0.01pp2q-54.6%-$2.0M
PALISADE BIO INCPALI$1.6M750,0000.17%+0.13pp3q+172.7%+$992.8K
AMANAT ACQUISITION CORPAMAN$1.5M150,0000.16%-newNEW
KALARIS THERAPEUTICS INCKLRS$1.5M360,0000.16%-0.01pp3qHELD
QUINCE THERAPEUTICS INC$1.3M72,2510.14%-newNEW
LIPOCINE INC NEWLPCN$1.3M508,5560.14%-0.19pp3qHELD
IMMUNOME INCIMNM$1.3M60,0000.14%-newNEW
ELICIO THERAPEUTICS INC OPTELTX$1.2M100,0000.13%-newNEW
PLIANT THERAPEUTICS INCPLRX$1.1M1,000,0000.12%-newNEW
IMMUNIC INCIMUX$1.0M67,4640.11%-newNEW
QUOIN PHARMACEUTICALS LTDQNRX$1.0M211,5380.11%flat3qHELD
EQUILLIUM INCEQ$971.4K303,5550.10%+0.06pp4qHELD
NEURONETICS INCSTIM$911.5K701,1820.10%+0.02pp6qHELD
FAETH THERAPEUTICS INCFTH$884.6K35,3860.10%+0.08pp5q+457.2%+$725.9K
FRACTYL HEALTH INCGUTS$873.8K1,100,0000.09%+0.05pp4qHELD
CYBIN INCHELP$873.5K132,1530.09%+0.04pp8qHELD
FIRST TRACKS BIOTHERAPEUTICSTRAX$860.6K42,7750.09%-newNEW
VERASTEM INCVSTM$817.0K213,8650.09%flat3qHELD
DIREXION SHARES ETF TRUSTLABD$815.9K105,8220.09%-0.05pp4qHELD
PEPGEN INCPEPG$804.9K447,1650.09%-0.02pp6qHELD
ACADIA PHARMACEUTICALS INCACAD$710.9K28,0990.08%+0.03pp2qHELD
CNS PHARMACEUTICALS INCCNSP$649.3K135,8300.07%+0.06pp3q+196.4%+$430.2K
LYELL IMMUNOPHARMA INCLYEL$577.2K41,0810.06%flat5qHELD
WAVE LIFE SCIENCES LTDWVE$495.5K85,2850.05%flat5qHELD
IMMATICS N.VIMTX$492.0K48,5690.05%+0.01pp5qHELD
PASSAGE BIO INCPASG$485.6K99,5170.05%+0.01pp2q+46.1%+$153.2K
NEXTCURE INCNXTC$461.3K288,3030.05%-0.15pp3q+21.0%+$80.0K
FORTE BIOSCIENCES INCFBRX$445.7K20,9720.05%-0.20pp7q-82.4%-$2.1M
SOLID BIOSCIENCES INCSLDB$429.1K42,9560.05%-0.11pp4q-83.8%-$2.2M
TRAWS PHARMA INCTRAW$403.2K478,1420.04%-0.06pp7q-29.5%-$168.7K
LEXICON PHARMACEUTICALS INCLXRX$395.2K164,6740.04%+0.02pp7qHELD
ADLAI NORTYE LTDANL$389.8K33,8990.04%+0.02pp2qHELD
INMED PHARMACEUTICALS INCINM$379.8K245,0250.04%-newNEW
VIKING THERAPEUTICS INCVKTX$379.1K9,7170.04%+0.02pp6qHELD
MACROGENICS INCMGNX$346.0K74,8930.04%+0.02pp10qHELD
HYPERLIQUID STRATEGIES INCPURR$236.1K30,0010.03%+0.01pp3qHELD
EVAXION ASEVAX$231.6K74,6980.02%flat6qHELD
CARTESIAN THERAPEUTICS INCRNAC$216.8K20,8070.02%+0.01pp9qHELD
COMPASS PATHWAYS PLCCMPS$212.2K15,0000.02%-0.28pp4q-97.8%-$9.3M
NEUPHORIA THERAPEUTICS INCNEUP$207.3K47,4430.02%+0.01pp3qHELD
VOYAGER THERAPEUTICS INCVYGR$185.7K53,0630.02%flat13qHELD
VYNE THERAPEUTICS INCVYNE$172.4K264,9120.02%+0.01pp5qHELD
BIOCRYST PHARMACEUTICALS INCBCRX$167.6K16,7560.02%-newNEW
ENVERIC BIOSCIENCES INCENVB$138.0K100,0020.01%-newNEW
PMV PHARMACEUTICALS INCPMVP$119.4K89,1360.01%flat4qHELD
VISTAGEN THERAPEUTICS INCVTGN$117.3K519,0770.01%-0.01pp7qHELD
CHEMOMAB THERAPEUTICS LTDCMMB$83.9K51,7930.01%flat4qHELD
NYXOAH S ANYXH$80.0K47,3580.01%flat5qHELD
AIRSCULPT TECHNOLOGIES INCAIRS$73.8K16,3980.01%flat5qHELD
MANGOCEUTICALS INCMGRX$52.5K138,1460.01%flat3qHELD
COMPASS THERAPEUTICS INCCMPX$39.4K18,0000.00%flat3qHELD
THERIVA BIOLOGICS INCTOVX$28.0K112,0760.00%flat6qHELD
GLUCOTRACK INCGCTK$14.6K45,8300.00%flat3qHELD
AETHLON MED INCAEMD$11.8K14,3640.00%flat3qHELD
JASPER THERAPEUTICS INCJSPR$10.1K24,0930.00%flat10qHELD
BIOMX INCPHGE$6.8K19,4730.00%-0.01pp3qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 93.0%Other sectors 1.4%Not classified 5.6%
 
SectorValueShare
Biotech & Pharma$863.2M93.0%
Other sectors$12.8M1.4%
Not classified$52.2M5.6%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$928.2M1372918303147.1%45
Q1 2026$1.2B1392427183349.7%45
Q4 2025$1.3B1484726623844.8%49
Q3 2025$990.4M1394822332343.8%45
Q2 2025$520.6M1142514275247.4%45
Q1 2025$811.5M1413523334160.6%45
Q4 2024$735.3M1474716252146.1%45
Q3 2024$717.2M121408301448.1%45
Q2 2024$574.1M951713242257.9%45
Q1 2024$912.0M1002622292745.7%47
Q4 2023$1.1B101267153246.7%45
Q3 2023$831.4M1073825242553.1%45
Q2 2023$627.9M943211213552.7%45
Q1 2023$440.7M97369191147.9%45
Q4 2022$414.5M7298241959.7%45
Q3 2022$501.8M82277425852.0%45
Q2 2022$548.4M1132113407752.6%43
Q1 2022$760.5M16919123111650.9%43
Q4 2021$671.3M166259463249.8%45
Q3 2021$1.4B17339181024344.9%46
Q2 2021$1.2B1772126558240.8%49
Q1 2021$3.0B2388636473137.8%140
Q4 2020$2.3B1837422362848.4%43
Q3 2020$1.4B1375220304146.7%47
Q2 2020$1.3B1264112333041.0%45
Q1 2020$1.3B115482192455.3%45
Q4 2019$617.2M91000052.1%31

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.